Blunted ACTH and cortisol responses to systemic injection of corticotropin-releasing hormone (CRH) in fibromyalgia: Role of somatostatin and CRH-binding protein

Annals of the New York Academy of Sciences

Volumn 966, Issue , 2002, Pages 483-490

  Riedel, Walter ^a   Schlapp, Ulrike ^a   Leck, Stefanie ^b   Netter, Petra ^b   Neeck, Gunther ^c  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c KERCKHOFF HEART CENTER   (Germany)

Author keywords

ACTH; Corticotropin releasing hormone; Cortisol; CRH binding protein; Fibromyalgia; Somatostatin

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; GROWTH HORMONE; HYDROCORTISONE; SOMATOSTATIN;

ADULT; CHRONIC PAIN; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FIBROMYALGIA; HORMONE RELEASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MUSCULOSKELETAL DISEASE; STRESS;

EID: 0036307345     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb04251.x     Document Type: Conference Paper

References (33)

1. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome
2. Psychological aspects of fibromyalgia syndrome: A component of the dysfunctional spectrum syndrome
3. Hypothalamic-pituitary-adrenal axis pertubations in patients with fibromyalgia
4. Neurohormonal perturbations in fibromyalgia
5. Evidence that abnormalities of central neurohormonal systems are keys to understanding fibromyalgia and chronic fatigue syndrome
6. Hypothalamic control of adrenocorticotropin secretion: Advances since the discovery of 41-residue corticotropin-releasing factor
7. The concepts of stress and stress system disorders: Overview of physical and behavioral homeostasis
8. Thyroid function in patients with fibromyalgia syndrome
9. Neuromediator and hormonal perturbations in fibromyalgia syndrome: Results of chronic stress?
10. Secretory pattern of GH, TSH, thyroid hormones, ACTH, cortisol, FSH, and LH in patients with fibromyalgia syndrome following systemic injection of the relevant hypothalamic-releasing hormones
11. Low levels of somatomedin C in patients with the fibromyalgia syndrome: A possible link beetween sleep and muscle pain
12. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia
13. Somatomedin C (insulin-like growth factor 1) levels decrease during acute changes of stress-related hormones. Relevance for fibromyalgia
14. Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome
15. A controlled study on serum insulin-like growth factor-I and urinary excretion of growth hormone in fibromyalgia
16. Ovine corticotropin-releasing factor stimulates somatostatin secretion from cultured brain cells
17. Glucocorticoids: Potent inhibitors and stimulators of growth hormone secretion
18. Half-time of endogeneous growth hormone (GH) disappearance in normal man after stimulation of GH secretion by CH-releasing hormone and suppression with somatostatin
19. Physiologic role of somatostatin in the control of growth hormone and thyrotropin secretion
20. Antiserum to somatostatin prevents stress-induced inhibition of growth hormone secretion in the rat
21. The somatostatin analogue octreotide modulates iodothyronine deiodinase activity and pituitary neuromedin B
22. Effect of centrally administered somatostatin on pituitary thyrotropes in male rats
23. Somatostatin treatment reduces the exaggerated response of adrenocorticotropin hormone and cortisol to corticotropin-releasing hormone in polycystic ovary syndrome
24. Effects of centrally applied somatostatin on pituitary adrenocorticotropes in female rats
25. Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins
26. Mouse models of altered CRH-binding protein expression
27. Sexually dimorphic expression of pituitary CRH-binding protein in mice
28. The pathophysiology of circulating corticotropin-releasing hormone-binding protein levels in the human
29. Maternal hypothalamic-pituitary-adrenal axis in pregnancy and the postpartum period: Postpartum-related disorders
30. The effect of reproductive events and alterations of sex hormone levels on the symptoms of fibromyalgia
31. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1
32. Peripheral but not intracerebroventricular corticotropin-releasing hormone (CRH) produces antinociception which is not opioid mediated
33. Overproduction of corticotropin-releasing factor in transgenic mice: A genetic model of anxiogenic behavior